News
RBC Capital initiated coverage of BeiGene (ONC) with an Outperform rating and $312 price target RBC sees a path to robust revenue growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback